Trials and PIs
View all posts »Dalcetrapib in patients with recent ACS with Dr Gregory Schwartz
Nov 9, 2012 09:07 EST-
0Comments
-
Read later
Dr Gregory Schwartz (University of Colorado, Denver) talks to Dr Michael Blaha (Johns Hopkins, Baltimore, MD) about the effects of the cholesteryl ester transfer protein inhibitor dalcetrapib in patients with recent ACS.
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
